Literature DB >> 3173660

Suppression of splenic natural killer cell activity in rats with brain tumors.

H Imaya1, H Matsuura, M Kudo, S Nakazawa.   

Abstract

After inoculating 9L glioma cells into the brains or into subcutaneous regions of the back of rats, we investigated splenic natural killer (NK) cell activity for 3 weeks using a 4-hour 51Cr release assay. Only rats with brain tumors showed decreased splenic NK cell activity. The spleens of these rats were morphologically small and atrophic. Expansive brain tumors were compressing the basal ganglia, thalamus, and hypothalamus after 2 weeks, and the rats ultimately died of cerebral herniation, usually by 3 weeks after inoculation. The decreased splenic NK cell activity in rats with brain tumors might be the result of neuroimmunomodulation secondary to hypothalamic dysfunction due to increasing tumor compression.

Entities:  

Mesh:

Year:  1988        PMID: 3173660     DOI: 10.1227/00006123-198807000-00005

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  3 in total

1.  Comparison of lymphokine-activated killer activities between thymocytes and splenocytes in rats with brain tumors.

Authors:  H Matsuura; H Imaya
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

2.  Progressive splenomegaly with increasing extramedullary haematopoiesis in subcutaneous 9L-glioma bearing rats.

Authors:  H Imaya; M Kudo; H Matsuura
Journal:  Int J Exp Pathol       Date:  1993-02       Impact factor: 1.925

3.  Expression of a soluble transforming growth factor-beta (TGFbeta) receptor reduces tumorigenicity by regulating natural killer (NK) cell activity against 9L gliosarcoma in vivo.

Authors:  Timothy F Witham; Lorissa Villa; Tianbing Yang; Ian F Pollack; Hideho Okada; Paul D Robbins; William H Chambers
Journal:  J Neurooncol       Date:  2003 Aug-Sep       Impact factor: 4.130

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.